Danielle was diagnosed with Immune Thrombocytopenia in June 2015. Looking and feeling healthy, she thought that she just ‘bruised like a peach’ and that, along with her other symptoms from over the years were considered normal. Then in June 2015, after a trip to the hospital with what she thought was the flu, a full blood count identified Danielle as having ITP. Luckily, her diagnosis was made under the trusty skills of haematologist and one of Australia’s leading experts in ITP, Dr Robert Bird.
The interim results for the I-WISh survey undertaken by Novartis, which collaborated with 480 health care providers across 13 countries, found that a high percentage of patients with Immune Thrombocytopenia experienced negative impacts to their quality of life due to the immune disease.